Aster Insights
Kyle Frazier has a diverse work experience spanning various industries. Kyle currently works at M2GEN as the Medical Informatics Data Conversion Lead, where they support complex assessments, analytics, data transfer, and research projects. Prior to this, they held roles as a Medical Informatics Analyst II and an ORIEN Project Data Analyst II at the same company.
Before joining M2GEN, Kyle worked at Orlando Health as a Corporate HIM Analyst, where they were responsible for analyzing and monitoring EMR deficiencies and managing office processes.
Kyle also has experience as a Graduate Student Intern at Florida Hospital, where they assisted in research projects and implemented processes to improve operational and clinical efficiency.
Additionally, Kyle worked at Target as an Assets Protection specialist, focusing on promoting safety and preventing incidents on the property. Kyle also served in the US Army for a short period in a Leadership Training Course.
Kyle Frazier earned a Bachelor of Science (B.S.) degree in Health Services/Allied Health/Health Sciences, General from the University of Central Florida from 2005 to 2009. Kyle then pursued a Master of Science (M.S.) degree in Health Service Administration from the same university, completing it from 2009 to 2011.
Aster Insights
We believe that personalized medicine starts with a complete view of an individual across their lifetime. Our company was founded in 2006 on the unique principle that informed consent from patients entrusting us with a lifetime connection to their health information, paired with deep partnerships across academia and the life sciences industry, would unlock critical advances in curing cancer. Aster Insights leads the Oncology Research Information Exchange Network (ORIEN®), a consortium of the nation’s leading academic cancer centers that conduct Total Cancer Care®, the world’s largest and longest running observational research study in oncology. TCC® serves as the foundation for novel insights that power oncology breakthroughs. As a long-time innovator in oncology, Aster Insights has world-class expertise in accelerating the life cycle of oncology medical product development. Our solutions are based on scientific and clinical intelligence and strengthened by our unique partnership with patients, academia, and industry. We empower our partners to uncover new targets and biomarkers, enhance cancer detection, deepen our understanding of new treatments, discover new indications, and accelerate clinical trials. Together, we are changing the way cancer is studied, treated, and prevented.